APX005M is a CD40 agonist antibody.[103] Recently, 2 early-stage studies ([NCT03123783] and [NCT03502330]) related to APX005M have been conducted for the treatment of NSCLC and other cancers. The gene discussed is CD40; the disease is cancer.